Analystreport

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its price target lowered by analysts at SVB Leerink LLC from $30.00 to $22.00. They now have an "outperform" rating

Aurinia Pharmaceuticals Inc - Common Shares  (AUPH) 
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.auriniapharma.com